/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Ekso Bionics Holdings, Inc.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$4.67 -0.0391(-3.91%) EKSO at 04 Dec 2025 04:30 PM Medical Instruments & Supplies
Lowest Today 4.335
Highest Today 4.79
Today’s Open 4.79
Prev. Close 4.6
52 Week High 14.97
52 Week Low 2.73
Day’s Range: Low 4.335 High 4.79
52-Week Range: Low 2.73 High 14.97
1 day return -
1 Week return -4.94
1 month return -13.33
3 month return +11.05
6 month return -
1 year return +539.65
3 year return +240.0
5 year return -19.63
10 year return -

Institutional Holdings

Fidelity Extended Market Index 0.36

Vanguard Institutional Extnd Mkt Idx Tr 0.31

World Impact SICAV Imptt Glbl Eq IEURAcc 0.14

Fidelity Series Total Market Index 0.08

Fidelity Total Market Index 0.04

Vanguard Instl Ttl Stck Mkt Idx Tr 0.04

NT Ext Equity Mkt Idx Fd - NL 0.03

Spartan Total Market Index Pool G 0.03

Northern Trust Extended Eq Market Idx 0.03

NT Ext Equity Mkt Idx Fd - L 0.03

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.02

Extended Equity Market Fund K 0.01

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.01

NT Ext Eq Mkt Indx Fd DC Lend T3 0.01

State St US Extended Mkt Indx NL Cl C 0.00

State St US Ttl Mkt Indx NL Cl A 0.00

Northern Trust Wilshire 5000 0.00

Spartan Extended Market Index Pool F 0.00

Extended Equity Market Fund M 0.00

SSgA U.S. Total Market Index Strategy 0.00

TWO SIGMA SECURITIES, LLC 0.00

Market Status

Strong Buy: 1

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 12.07 M

PB Ratio 1.2819

PE Ratio 0.0

Enterprise Value 14.64 M

Total Assets 26.65 M

Volume 76421

Company Financials

Annual Revenue FY23:16983000 17.0M, FY22:12912000 12.9M, FY21:11246000 11.2M, FY20:8882000 8.9M, FY19:13917000 13.9M

Annual Profit FY23:8388000 8.4M, FY22:6214000 6.2M, FY21:6749000 6.7M, FY20:5070000 5.1M, FY19:6764000 6.8M

Annual Net worth FY23:-15162000 -15.2M, FY22:-14604000 -14.6M, FY21:-8432000 -8.4M, FY20:-16954000 -17.0M, FY19:-11694000 -11.7M

Quarterly Revenue Q3/2025:4227000 4.2M, Q2/2025:2057000 2.1M, Q1/2025:3375000 3.4M, Q3/2024:4129000 4.1M, Q2/2024:4950000 5.0M

Quarterly Profit Q3/2025:2549000 2.5M, Q2/2025:819000 0.8M, Q1/2025:1806000 1.8M, Q3/2024:2209000 2.2M, Q2/2024:2637000 2.6M

Quarterly Net worth Q3/2025:-1421000 -1.4M, Q2/2025:-2709000 -2.7M, Q1/2025:-2891000 -2.9M, Q3/2024:-2072000 -2.1M, Q2/2024:-2416000 -2.4M

Fund house & investment objective

Company Information Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EVO, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. It also offers EksoCare offering an extended warranty and premium service options, repairs and maintenance services, and training programs. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

Organisation Medical Instruments & Supplies

Employees 61

Industry Medical Instruments & Supplies

CEO Mr. Scott G. Davis

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow